Showing 1221-1230 of 7751 results for "".
Are Municipal Bonds Right for You?
https://practicaldermatology.com/topics/practice-management/are-municipal-bonds-right-for-you/20707/Do they make sense today and are they appropriate if tax rates are positioned to decline?Biologics and Pediatric Psoriasis
https://practicaldermatology.com/topics/practice-management/biologics-and-pediatric-psoriasis/21196/Though data has been lacking in recent years, the use of biologics in pediatric and adolescent patients deserves more consideration.Take 5: Recent Findings on Barrier Function and Repair
https://practicaldermatology.com/columns/take-5/take-5-recent-findings-on-barrier-function-and-repair/21831/Data continue to elucidate the significance of the skin barrier in maintaining skin health and guide clinicians in the best approaches to barrier repair.Cultural Competence in Dermatology
https://practicaldermatology.com/topics/skin-of-color/cultural-competence-in-dermatology/23591/Acknowledging cultural differences, keeping an open mind, and showing empathy go a long way toward improving the patient’s care experience.Case Study: Recurrent Generalized Pustular Psoriasis
https://practicaldermatology.com/issues/august-2025/recurrent-generalized-pustular-psoriasis/36711/This article reports the case of a 74-year-old white man with a history of psoriatic arthritis and congestive heart failure who presented with two separate episodes of GPP. Both of these episodes were associated with hypocalcemia and required inpatient hospitalization.Characterizing “Obese Skin”: Aesthetic Considerations Following GLP-1-Induced Rapid Weight Loss
https://practicaldermatology.com/topics/cosmetic/characterizing-obese-skin/24565/Characterizing “Obese Skin”: Aesthetic Considerations Following GLP-1-Induced Rapid Weight Loss'Clean Beauty' in Dermatology: A Scoping Review
https://practicaldermatology.com/issues/july-2025/clean-beauty/36492/The emergence of “clean beauty” as a consumer label has become a notable marketing trend, developed in the absence of standardized regulatory definitions, and it has been associated with shifts in consumer behaviors on a global scale.Clinical Data on Switching to Upadacitinib
https://practicaldermatology.com/series/updates-atopic-dermatitis/clinical-data-on-switching-to-upadacitinib/36534/Clinical investigator Christopher Bunick, MD, PhD, discusses results from the LEVEL UP trial among patients who switched from dupilumab to upadacitinib for atopic dermatitis.Technology: The Threat and the Opportunity
https://practicaldermatology.com/issues/june-2024/technology-the-threat-and-the-opportunity/26538/Joel Schlessinger, MD, chief cosmetic surgery editor of Practical Dermatology, talks about the perils and promise brough about by shifts in technology, both in his own practice and in the wider field of dermatology.Expert Panel Consensus on Uniform Nomenclature and Diagnosis for Neuropathic Pruritus
https://practicaldermatology.com/issues/june-2024/expert-panel-consensus-on-uniform-nomenclature-and-diagnosis-for-neuropathic-pruritus/26549/Dr. Peter Lio and colleagues look at a 2023 article working to establish a consensus on uniform nomenclature and diagnosis for neuropathic pruritis.